Amgen Inc (NASDAQ: AMGN)
DRUGS - BiotechnologySector: Health Care
Stock price data as of 01/21/2022
Closing price: 227.72
| Support price level: | $219.25 |
| Resistance price level: | N/A |
| Relative strength index (14-day RSI) | 55.2 |
| Beta | 0.54 |
- With a -10.2 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
- The price of this low-beta stock is expected to increase by 0.54% for every 1% increase in the S&P-500.
- Volatility is forecast to fall over the next month.
- Price broke above prior resistance level - a short-term bullish signal.
| Low | High | Price as % of Range |
| $198.88 | $259.14 | 51.2% |
| 200 day | 50 day | 20 day | 10 day |
| $228.53 | $217.23 | $228.42 | $230.98 |
| Historical (5 year) |
Last month | Current estimate | Next month forecast |
| 24.8% | 20.0% | 21.0% | 23.1% |
- 5.7% in the next week.
- 13.1% in the next month.
- 47.1% in the next year.
